UROL ONCOL-SEMIN ORI 润色咨询

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

出版年份:1995 年文章数:2742 投稿命中率: 开通期刊会员,数据随心看

出版周期:Bimonthly 自引率:5.0% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊简介

期刊简介
GetPortalImpactFactorByIdResp(projectId=1, id=9caf7211, cover=https://img.medsci.cn/images/journal/cover/2021/tuV_202109271316461000.jpg, fullname=UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, abbr=UROL ONCOL-SEMIN ORI, pyear=1995, frequence=Bimonthly, articleNumbers=2742, citedSelf2015=5.0, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均2.57月, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=1078-1439, greenSci=https://www.greensci.net/search?kw=1078-1439, scijournal=https://www.scijournal.org/impact-factor-of-UROL-ONCOL-SEMIN-ORI.shtml, medsciHotlightString=null, medsciHotlightRealtime=4.612, medsciHotlight=6.704, medsciHotlight5year=5.25681, citescore=0.0, hIndex=69, impactFactor=2.7, orgnization=Elsevier Inc., orgnizationUrl=http://www.elsevier.com, country=Netherlands, countryCn=荷兰, isOa=0, isOaString=否, sciScie=Science Citation Index Expanded|Current Contents - Clinical Medicine, bigclassCas=医学 3区, smallclassCas=医学 3 区, website=http://www.urologiconcology.org/, websiteHits=8177, guideForAuthor=https://www.elsevier.com/journals/urologic-oncology-seminars-and-original-investigations/1078-1439/guide-for-authors, guideForAuthorHits=339, submitWebsite=https://www.editorialmanager.com/uro/, submitWebsiteHits=2813, content=<p>Published by Elsevier Science. ISSN: 1078-1439.<br /><br />Urologic Oncology is dedicated to the coverage of all aspects of cancers of the genitourinary system. The journal will publish original research papers from the laboratory and the clinic, review articles, and discussions of controversies. Physicians and scientists alike should find both practical and provocative reading in topics ranging from genetics and cell biology, newly developed diagnostic techniques, and changing approaches to treatment in the broad field of urologic oncology. The target audience is international and multidisciplinary, and is designed to include urologists, medical oncologists, radiation oncologists, pathologists, cell and molecular biologists, geneticists and any clinician or investigator working in or having an interest in this field. The journal's major objective is to stimulate new ideas and research with a multidisciplinary base in both the laboratory and in the clinic of the various problems in oncology that affect the genitourinary system.</p>, totalCites=7406, brief=UROL ONCOL-SEMIN ORI杂志医学行业,“<strong><a target="_blank" href="/sci/index.do?smallclass=泌尿学与肾脏学" >泌尿学与肾脏学</a></strong>”子行业的中等级别杂志, articleType=论著为主,其它类型文章约占5-10%, medsciHeat=<span style="color: #990000;">暗红</span>, medsciComment=UROL ONCOL-SEMIN ORI杂志级别还可以,但是相对来说,比较冷门,关注人数偏少,有些可能是国内不太熟悉,但该杂志在国际仍然有相当知晓度的。因为缺少中国人投稿,稿源可能未必丰富,发表有可能有很大的机会哦。, medsciExplanation=MedSci期刊指数是根据中国科研工作者(含医学临床,基础,生物,化学等学科)对SCI杂志的认知度,熟悉程度,以及投稿的量等众多指标综合评定而成。当然,具体的,您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=9caf7211'>投稿经验系统</a>”,进行综合判断,这更是大家的实战经验,值得分享和参考。<br> 注意,上述MedSci期刊指数采用MedSci专利技术,由计算机系统自动计算,并给出建议,存在不准确的可能,仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=119, tagName=肿瘤, createdHits=15), ImpactFactorTagDto(id=516, tagName=癌症, createdHits=13), ImpactFactorTagDto(id=330, tagName=肾癌, createdHits=2), ImpactFactorTagDto(id=781, tagName=前列腺癌, createdHits=2), ImpactFactorTagDto(id=482, tagName=肾脏, createdHits=1), ImpactFactorTagDto(id=988, tagName=预后, createdHits=1), ImpactFactorTagDto(id=1559, tagName=肿瘤学, createdHits=1), ImpactFactorTagDto(id=70177, tagName=泌尿学, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=2.22), GetImpactFactorCiteScoreListResponse(year=2017, citescore=2.41), GetImpactFactorCiteScoreListResponse(year=2018, citescore=2.61), GetImpactFactorCiteScoreListResponse(year=2019, citescore=4.8), GetImpactFactorCiteScoreListResponse(year=2020, citescore=0.0)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=4.963), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=4.352), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=5.081), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=5.351), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=4.612)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Urology , rank=11/100), GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Oncology , rank=134/321)], totalJcrAreaList=[], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1078-1439[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS[ta], article_number=327, article_number_cn=27, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)
期刊名称
UROL ONCOL-SEMIN ORI/UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
ISSN
1078-1439
影响指数话题
预警等级
MedSci期刊指数
4.612 (MedSci实时期刊指数) | 5.25681 (5年期刊指数)
CiteScore值
0.0
h-index
69
h5-median
暂无数据
出版社/管理机构
杂志由 Elsevier Inc. 出版或管理
出版国家/地区
Netherlands 荷兰
出版周期
Bimonthly
出版年份
1995
是否OA
被收录情况
Science Citation Index Expanded|Current Contents - Clinical Medicine
JCR分区
暂无数据
中科院分区
大类:医学 3区
小类:医学 3 区